HUE040487T2 - Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások - Google Patents

Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások

Info

Publication number
HUE040487T2
HUE040487T2 HUE13710253A HUE13710253A HUE040487T2 HU E040487 T2 HUE040487 T2 HU E040487T2 HU E13710253 A HUE13710253 A HU E13710253A HU E13710253 A HUE13710253 A HU E13710253A HU E040487 T2 HUE040487 T2 HU E040487T2
Authority
HU
Hungary
Prior art keywords
arodopsin
chop2
mutations
identification
channel
Prior art date
Application number
HUE13710253A
Other languages
English (en)
Hungarian (hu)
Inventor
Zhuo-Hua Pan
Original Assignee
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wayne State filed Critical Univ Wayne State
Publication of HUE040487T2 publication Critical patent/HUE040487T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/405Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HUE13710253A 2012-03-05 2013-03-05 Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások HUE040487T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261606663P 2012-03-05 2012-03-05

Publications (1)

Publication Number Publication Date
HUE040487T2 true HUE040487T2 (hu) 2019-03-28

Family

ID=47892055

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13710253A HUE040487T2 (hu) 2012-03-05 2013-03-05 Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások

Country Status (16)

Country Link
US (3) US10947281B2 (https=)
EP (1) EP2822964B1 (https=)
JP (3) JP6395611B2 (https=)
KR (1) KR102137717B1 (https=)
CN (2) CN111378020A (https=)
AU (4) AU2013230112A1 (https=)
CA (1) CA2866405A1 (https=)
DK (1) DK2822964T3 (https=)
EA (1) EA201491643A1 (https=)
ES (1) ES2703324T3 (https=)
HU (1) HUE040487T2 (https=)
MX (1) MX360085B (https=)
NZ (1) NZ629843A (https=)
PL (1) PL2822964T3 (https=)
PT (1) PT2822964T (https=)
WO (1) WO2013134295A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101484005A (zh) 2006-05-04 2009-07-15 韦恩州立大学 通过向体内递送视紫红质核酸恢复视觉响应
WO2011140279A1 (en) 2010-05-04 2011-11-10 Wayne State University Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
CA2866405A1 (en) * 2012-03-05 2013-09-12 Wayne State University Identification of channelopsin-2 (chop2) mutations and methods of use
EP2968476B1 (en) 2013-03-14 2021-05-05 Wayne State University A plasmin for use in enhancing delivery of therapeutic compounds to the eyes or for improving vision
JP6469669B2 (ja) 2013-07-08 2019-02-13 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se オキシムエステル光開始剤
EP4678754A3 (en) 2014-03-11 2026-04-08 Wayne State University A modified mglur6 promoter and methods of use
US20170319669A1 (en) 2016-05-03 2017-11-09 Wayne State University Method of enhancing viral-mediated gene delivery
CN109476720A (zh) * 2016-06-03 2019-03-15 马克斯-普朗克科学促进协会 通道视紫红质的突变型光诱导离子通道
EP3504227A1 (en) * 2016-08-29 2019-07-03 Wayne State University Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof
JP6779546B2 (ja) * 2016-11-06 2020-11-04 ナノスコープ テクノロジーズ エルエルシーNanoscope Technologies Llc 視力回復のための多特性オプシンによる光遺伝学的調節及びその別の用途
US20200115419A1 (en) * 2017-04-12 2020-04-16 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. New optogenetic tool
DK3720428T3 (da) * 2017-12-04 2023-03-20 Salvat Lab Sa Oftalmisk topisk sammensætning omfattende dobesilsyre til behandling af sygdomme i det bageste øjensegment
JP6567153B1 (ja) * 2018-09-28 2019-08-28 学校法人東北工業大学 対象化合物の特性の予測を行うための方法、コンピュータシステム、プログラム
EP4704877A2 (en) * 2023-04-24 2026-03-11 Nanoscope Therapeutics Inc. Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4498919A (en) 1983-10-31 1985-02-12 Corning Glass Works Method for making colored photochromic prescription ophthalmic lenses
US6610287B1 (en) 1990-04-16 2003-08-26 The General Hospital Corporation Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
US5827702A (en) 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
EP0977880A2 (en) 1997-04-21 2000-02-09 University Of Florida Materials and methods for treatment of retinal diseases
CA2346262A1 (en) 1998-09-17 2000-03-23 University Of Florida Methods for treatment of degenerative retinal diseases
US7056502B2 (en) 2000-04-28 2006-06-06 The Trustees Of The University Of Pennsylvania Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids
WO2002082904A2 (en) 2001-04-13 2002-10-24 The Trustees Of The University Of Pennsylvania Method of treating or retarding the development of blindness
AU2002323210A1 (en) 2001-08-16 2003-03-03 Sloan Kettering Institute For Cancer Research Bio-synthetic photostimulators and methods of use
DE10216005A1 (de) 2002-04-11 2003-10-30 Max Planck Gesellschaft Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle
WO2004009022A2 (en) 2002-07-18 2004-01-29 The General Hospital Corp. Method for augmenting vision in persons suffering from photoreceptor cell degeneration
US7186699B2 (en) 2003-06-03 2007-03-06 Cell Genesys, Inc. Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
US7427138B2 (en) 2003-11-05 2008-09-23 Neurovision, Inc. Method and apparatus for improving visual perception
EP1919497B1 (en) 2005-07-22 2020-02-12 The Board of Trustees of the Leland Stanford Junior University Light-activated cation channel and uses thereof
CN101484005A (zh) 2006-05-04 2009-07-15 韦恩州立大学 通过向体内递送视紫红质核酸恢复视觉响应
WO2011140279A1 (en) * 2010-05-04 2011-11-10 Wayne State University Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
KR101945962B1 (ko) * 2010-09-08 2019-02-08 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. 돌연변이 채널로돕신 2
CA2866405A1 (en) * 2012-03-05 2013-09-12 Wayne State University Identification of channelopsin-2 (chop2) mutations and methods of use
KR101639859B1 (ko) 2014-03-06 2016-07-14 포항공과대학교 산학협력단 광 자극에 의한 미토콘드리아 활성의 시공간적 가역 조절 방법

Also Published As

Publication number Publication date
KR20140132401A (ko) 2014-11-17
MX360085B (es) 2018-10-10
US20150044181A1 (en) 2015-02-12
AU2021245195B2 (en) 2023-09-28
EP2822964A1 (en) 2015-01-14
HK1205744A1 (en) 2015-12-24
EP2822964B1 (en) 2018-08-22
WO2013134295A1 (en) 2013-09-12
CN111378020A (zh) 2020-07-07
AU2019216638A1 (en) 2019-09-05
NZ629843A (en) 2017-03-31
PL2822964T3 (pl) 2019-05-31
JP2015510759A (ja) 2015-04-13
CA2866405A1 (en) 2013-09-12
ES2703324T3 (es) 2019-03-08
KR102137717B1 (ko) 2020-07-27
AU2013230112A1 (en) 2014-09-25
AU2019216638B2 (en) 2021-07-08
AU2017239601B2 (en) 2019-05-16
JP2019193656A (ja) 2019-11-07
NZ727041A (en) 2022-01-28
JP6395611B2 (ja) 2018-09-26
DK2822964T3 (en) 2018-12-10
AU2021245195A1 (en) 2021-11-04
PT2822964T (pt) 2018-11-29
JP2018134098A (ja) 2018-08-30
US20250066431A1 (en) 2025-02-27
US10947281B2 (en) 2021-03-16
EA201491643A1 (ru) 2015-02-27
US20220033449A1 (en) 2022-02-03
AU2017239601A1 (en) 2017-10-26
MX2014010664A (es) 2015-03-06
CN104334575A (zh) 2015-02-04

Similar Documents

Publication Publication Date Title
HUE040487T2 (hu) Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások
HUE054881T2 (hu) Nyomtatási rendszer és eljárás
HUE037021T2 (hu) DLL3- modulátorok és eljárások alkalmazásukra
DK2925782T3 (da) Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf
HUE044123T2 (hu) Csepegtetõ készülék és eljárás
EP2930714A4 (en) Singing voice synthesizing system and singing voice synthesizing method
HUE043260T2 (hu) Képfeldolgozó eszköz és képfeldolgozási eljárás
EP2698985A4 (en) Imaging system and imaging method
DK2909427T3 (da) Tætningsanordning og -fremgangsmåde
HUE053410T2 (hu) Alkalmazási eljárás és alkalmazási berendezés
HUE045675T2 (hu) Eljárások és berendezés több felhasználói uplink összeköttetéshez
BR112014021287A2 (pt) Grampo cirúrgico
IL236002A0 (en) Aggregation of data bearers for carrier aggregation
HUE071157T2 (hu) Képdekódoló eljárás és képdekódoló berendezés
DK2917763T3 (da) Lidar-målesystem og lidar-målefremgangsmåde
DK2854883T3 (da) Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf
EP2700351A4 (en) ENDOSCOPIC SYSTEM
HUE037664T2 (hu) Állati takarmány és eljárás annak elõállítására
HUE045802T2 (hu) Berendezés és eljárás csökkentett jelzéssel rendelkezõ csatlakoztatott módhoz
BR112015005526A2 (pt) gabarito cirúrgico aprimorado
HUE040066T2 (hu) Eljárások és felszerelések tumorok molekuláris szubtipizálásához
HUE040336T2 (hu) Biológiai hatóanyagot és fluopikolidot tartalmazó készítmény
DK3003117T3 (da) Videolaryngoskop og laryngoskopindføringsdel
BR112014020761A2 (pt) Aparelho médico e método
HUE051632T2 (hu) Betegségek kezelésére szolgáló készítmények és eljárások